{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T21:07:02Z","timestamp":1771189622159,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.drugalcdep.2009.03.008","type":"journal-article","created":{"date-parts":[[2009,4,29]],"date-time":"2009-04-29T09:34:38Z","timestamp":1240997678000},"page":"37-43","source":"Crossref","is-referenced-by-count":58,"title":["Open-label dose-finding trial of buprenorphine implants (Probuphine)\u00ae for treatment of heroin dependence"],"prefix":"10.1016","volume":"103","author":[{"given":"Jason","family":"White","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Bell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John B.","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Makowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Farquharson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine L.","family":"Beebe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.drugalcdep.2009.03.008_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/10550490490440780","article-title":"French field experience with buprenorphine","volume":"13","author":"Auriacombe","year":"2004","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2009.03.008_bib2","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1097\/00002030-200411190-00010","article-title":"United Nations Reference Group on HIV\/AIDS Prevention and Care among IDU in Developing and Transitional Countries, Global overview of injecting drug use and HIV infection among injecting drug users","volume":"18","author":"Aceijas","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2009.03.008_bib3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0376-8716(83)90037-6","article-title":"The day-to-day criminality of heroin addicts in Baltimore-a study in the continuity of offence rates","volume":"12","author":"Ball","year":"1983","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2009.03.008_bib4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/09595230500537647","article-title":"Retention and attendance with supervised buprenorphine treatment; a case-note review","volume":"25","author":"Bell","year":"2006","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2009.03.008_bib5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1176\/appi.ajp.2007.07071058","article-title":"Data do not support buprenorphine as a first-line treatment for addiction","volume":"164","author":"Byrne","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2009.03.008_bib6","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2165\/00003088-200544070-00001","article-title":"Buprenorphine: clinical pharmacokinetics in the treatment of opioid dependence","volume":"44","author":"Elkader","year":"2005","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.drugalcdep.2009.03.008_bib7","series-title":"The Quantification Of Drug Caused Morbidity And Mortality In Australia","author":"English","year":"1995"},{"key":"10.1016\/j.drugalcdep.2009.03.008_bib8","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1046\/j.1360-0443.1999.94913376.x","article-title":"Buprenorphine versus methadone maintenance for the treatment of opioid dependence","volume":"94","author":"Fischer","year":"1999","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2009.03.008_bib9","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0376-8716(81)90096-X","article-title":"The Swedish methadone maintenance program: a controlled study","volume":"7","author":"Gunne","year":"1981","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2009.03.008_bib10","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3109\/00952998709001515","article-title":"Two new rating scales for opiate withdrawal","volume":"13","author":"Handelsman","year":"1987","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.drugalcdep.2009.03.008_bib11","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1001\/archpsyc.1993.01820190079008","article-title":"A 24-year follow-up of California narcotics addicts","volume":"50","author":"Hser","year":"1993","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2009.03.008_bib12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1360-0443.2004.00958.x","article-title":"Buprenorphine diversion and injection in Melbourne, Australia: an emerging issue?","volume":"100","author":"Jenkinson","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2009.03.008_bib13","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1056\/NEJM200011023431802","article-title":"A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence","volume":"343","author":"Johnson","year":"2000","journal-title":"N. Eng. J. Med."},{"key":"10.1016\/j.drugalcdep.2009.03.008_bib14","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1001\/jama.267.20.2750","article-title":"A controlled trial of buprenorphine treatment for opioid dependence","volume":"267","author":"Johnson","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2009.03.008_bib15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0376-8716(95)01186-2","article-title":"A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence","volume":"40","author":"Johnson","year":"1995","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2009.03.008_bib16","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1176\/appi.ajp.164.5.797","article-title":"A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: a randomized controlled trial","volume":"164","author":"Kakko","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2009.03.008_bib17","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/00005053-199306000-00004","article-title":"Buprenorphine versus methadone maintenance for opioid dependence","volume":"181","author":"Kosten","year":"1993","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.drugalcdep.2009.03.008_bib18","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1046\/j.1360-0443.1998.93454910.x","article-title":"Relationship of plasma buprenorphine and norbuprenorphine to withdrawal symptoms during dose induction, maintenance and withdrawal from sublingual buprenorphine","volume":"93","author":"Kuhlman","year":"1998","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2009.03.008_bib19","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000088578","article-title":"Co-morbidity of infectious and addictive diseases in St. Petersburg and the Leningrad region Russia","volume":"12","author":"Krupitsky","year":"2006","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.drugalcdep.2009.03.008_bib20","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/j.clinthera.2007.10.010","article-title":"Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study","volume":"29","author":"Landau","year":"2007","journal-title":"Clin. Ther."},{"key":"10.1016\/j.drugalcdep.2009.03.008_bib21","doi-asserted-by":"crossref","first-page":"774","DOI":"10.2105\/AJPH.91.5.774","article-title":"The impact of harm-reduction\u2013based methadone treatment on mortality among heroin users","volume":"91","author":"Langendam","year":"2007","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2009.03.008_bib22","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1111\/j.1360-0443.2007.01944.x","article-title":"Evaluation of a transdermal buprenorphine formulation in opioid detoxification","volume":"102","author":"Lanier","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2009.03.008_bib23","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1360-0443.1998.9344753.x","article-title":"Buprenorphine maintenance treatment of opiate dependence: a multicenter randomized clinical trial","volume":"93","author":"Ling","year":"1998","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2009.03.008_bib24","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/archpsyc.1996.01830050035005","article-title":"A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence","volume":"53","author":"Ling","year":"1996","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2009.03.008_bib25","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0376-8716(02)00322-8","article-title":"Opioid effects and opioid withdrawal during a 24h dosing interval in patients maintained on buprenorphine","volume":"69","author":"Lopatko","year":"2003","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2009.03.008_bib26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jsat.2006.11.009","article-title":"Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients","volume":"33","author":"Maremmani","year":"2007","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2009.03.008_bib27","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1046\/j.1360-0443.1998.9345157.x","article-title":"The efficacy of methadone maintenance interventions in reducing illicit opiate use. HIV risk behavior and criminality: a meta-analysis","volume":"93","author":"Marsch","year":"1998","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.drugalcdep.2009.03.008_bib28","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence (update of Cochrane Database Syst Rev 2003; (2): CD002207; PMID: 12804429)","author":"Mattick","year":"2004","journal-title":"Cochrane Database Syst. Rev."},{"issue":"4","key":"10.1016\/j.drugalcdep.2009.03.008_bib29","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","author":"Mattick","year":"2002","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2009.03.008_bib30","first-page":"1049","article-title":"Human immunodeficiency virus seroconversion among intravenous drug users in and out of treatment: an 18-month prospective follow-up","volume":"6","author":"Metzger","year":"1993","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.drugalcdep.2009.03.008_bib31","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00002030-199402000-00010","article-title":"HIV seroconversion in intravenous drug users in San Francisco 1985\u20131990","volume":"8","author":"Moss","year":"1994","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2009.03.008_bib32","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1126\/science.841320","article-title":"Conditioned narcotic withdrawal in humans","volume":"195","author":"O\u2019Brien","year":"1977","journal-title":"Science"},{"key":"10.1016\/j.drugalcdep.2009.03.008_bib33","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0376-8716(99)00140-4","article-title":"Buprenorphine: a controlled clinical trial on the efficacy in the treatment of opioid dependence","volume":"60","author":"Pani","year":"2000","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2009.03.008_bib34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0376-8716(00)00163-0","article-title":"Double-blind randomized trial of buprenorphine and methadone in opiate dependence","volume":"62","author":"Petitjean","year":"2001","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2009.03.008_bib35","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1081\/JA-120039392","article-title":"Characteristics of heroin addicts entering methadone maintenance treatment: quality of life and gender","volume":"39","author":"Puigdollers","year":"2004","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.drugalcdep.2009.03.008_bib36","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1360-0443.2006.01348.x","article-title":"An injection depot formulation of buprenorphine extended biodelivery and effects","volume":"101","author":"Sigmon","year":"2006","journal-title":"Addiction"},{"issue":"Suppl 1","key":"10.1016\/j.drugalcdep.2009.03.008_bib37","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1191\/0269216306pm1125oa","article-title":"Transdermal buprenorphine in cancer pain and palliative care","volume":"20","author":"Sittl","year":"2006","journal-title":"Palliat. Med."},{"key":"10.1016\/j.drugalcdep.2009.03.008_bib38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.drugalcdep.2003.08.006","article-title":"Open-label trial of an injection depot formulation of buprenorphine in opioid detoxification","volume":"73","author":"Sobel","year":"2004","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2009.03.008_bib39","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1176\/ajp.151.7.1025","article-title":"Comparison of buprenorphine and methadone in the treatment of opioid dependence","volume":"151","author":"Strain","year":"1994","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2009.03.008_bib40","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00004714-199602000-00010","article-title":"Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis and addiction severity index","volume":"16","author":"Strain","year":"1996","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2009.03.008_bib41","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0140-6736(85)92961-7","article-title":"Abuse of buprenorphine","volume":"2","author":"Strang","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2009.03.008_bib42","unstructured":"Substance Abuse and Mental Health Services Administration, 2007. Results from the 2006 National Survey on Drug Use and Health: National Findings (Office of Applied Studies, NSDUH Series H-32, DHHS Publication No. SMA 07-4293). Rockville, MD."},{"issue":"Suppl 1","key":"10.1016\/j.drugalcdep.2009.03.008_bib43","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000052036","article-title":"Comparison of buprenorphine and methadone in the treatment of opioid dependence. Swiss multicentre study","volume":"4","author":"Uehlinger","year":"1998","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.drugalcdep.2009.03.008_bib44","unstructured":"United Nations Office on Drug and Crime. World Drug Report, 2007. Available at: www.unodc.org. Accessed February 10, 2008."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871609000866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871609000866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T23:36:46Z","timestamp":1684971406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871609000866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":44,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0376871609000866"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2009.03.008","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}